Suchergebnisse - "Centis, Rosella"
-
1
Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence
ISSN: 1399-3003, 1399-3003Veröffentlicht: England 01.11.2017Veröffentlicht in The European respiratory journal (01.11.2017)Weitere Angaben
Journal Article -
2
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
ISSN: 1399-3003, 1399-3003Veröffentlicht: England 01.05.2017Veröffentlicht in The European respiratory journal (01.05.2017)“… Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant tuberculosis (XDR-TB) are lacking. This study aimed to …”
Weitere Angaben
Journal Article -
3
Drug resistant TB – latest developments in epidemiology, diagnostics and management
ISSN: 1201-9712, 1878-3511, 1878-3511Veröffentlicht: Canada Elsevier Ltd 01.11.2022Veröffentlicht in International journal of infectious diseases (01.11.2022)“… •DR- and MDR-TB are more frequent in contacts and patients previously treated.•Whole genome sequencing, rapid, consistent and sensitive, is very useful in …”
Volltext
Journal Article -
4
Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence
ISSN: 1399-3003, 1399-3003Veröffentlicht: England 01.02.2016Veröffentlicht in The European respiratory journal (01.02.2016)Weitere Angaben
Journal Article -
5
Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae
ISSN: 1399-3003, 1399-3003Veröffentlicht: England 01.03.2019Veröffentlicht in The European respiratory journal (01.03.2019)Weitere Angaben
Journal Article -
6
Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline
ISSN: 1399-3003, 1399-3003Veröffentlicht: England 01.03.2017Veröffentlicht in The European respiratory journal (01.03.2017)Weitere Angaben
Journal Article -
7
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review
ISSN: 1399-3003, 1399-3003Veröffentlicht: England 01.07.2018Veröffentlicht in The European respiratory journal (01.07.2018)Weitere Angaben
Journal Article -
8
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
ISSN: 1399-3003, 1399-3003Veröffentlicht: England 01.12.2019Veröffentlicht in The European respiratory journal (01.12.2019)“… The World Health Organization (WHO) recommends that countries implement pharmacovigilance and collect information on active drug safety monitoring (aDSM) and …”
Weitere Angaben
Journal Article -
9
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
ISSN: 1201-9712, 1878-3511, 1878-3511Veröffentlicht: Canada Elsevier Ltd 01.03.2020Veröffentlicht in International journal of infectious diseases (01.03.2020)“… •Updated clinical guidance on MDR-TB is needed.•Several new MDR-TB diagnostics have been recently approved by WHO to complement existing tools.•To design a …”
Volltext
Journal Article -
10
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis
ISSN: 1399-3003, 1399-3003Veröffentlicht: England 01.12.2012Veröffentlicht in The European respiratory journal (01.12.2012)“… Linezolid is used off-label to treat multidrug-resistant tuberculosis (MDR-TB) in absence of systematic evidence. We performed a systematic review and …”
Weitere Angaben
Journal Article -
11
Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review
ISSN: 1422-0067, 1422-0067Veröffentlicht: Switzerland MDPI 12.03.2016Veröffentlicht in International journal of molecular sciences (12.03.2016)“… Background: Carbapenems (ertapenem, imipenem, meropenem) are used to treat multidrug-resistant (MDR-) and extensively drug-resistant tuberculosis (XDR-TB), …”
Volltext
Journal Article -
12
Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination
ISSN: 1399-3003, 1399-3003Veröffentlicht: England 01.09.2013Veröffentlicht in The European respiratory journal (01.09.2013)“… The introduction of new rapid diagnostic tools for tuberculosis (TB) and the promising TB drugs pipeline together with the development of a new World Health …”
Weitere Angaben
Journal Article -
13
Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
ISSN: 1549-1676, 1549-1277, 1549-1676Veröffentlicht: United States Public Library of Science 01.08.2012Veröffentlicht in PLoS medicine (01.08.2012)“… Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic, expensive, and has generally poor outcomes. We undertook an individual patient data …”
Volltext
Journal Article -
14
Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes
ISSN: 1399-3003, 1399-3003Veröffentlicht: England 01.07.2013Veröffentlicht in The European respiratory journal (01.07.2013)“… A meta-analysis for response to treatment was undertaken using individual data of multidrug-resistant tuberculosis (MDR-TB) (resistance to isoniazid and …”
Weitere Angaben
Journal Article -
15
Post tuberculosis treatment infectious complications
ISSN: 1201-9712, 1878-3511, 1878-3511Veröffentlicht: Canada Elsevier Ltd 01.03.2020Veröffentlicht in International journal of infectious diseases (01.03.2020)“… •Patients with pulmonary tuberculosis (TB) are more susceptible to future lung disease and accelerated lung ageing.•Exacerbations of chronic obstructive …”
Volltext
Journal Article -
16
Post-tuberculosis sequelae and their socioeconomic consequences: worth investigating
ISSN: 2214-109X, 2214-109XVeröffentlicht: England Elsevier Ltd 01.12.2021Veröffentlicht in The Lancet global health (01.12.2021)Volltext
Journal Article -
17
Tuberculosis elimination: where are we now?
ISSN: 0905-9180, 1600-0617, 1600-0617Veröffentlicht: England European Respiratory Society 30.06.2018Veröffentlicht in European respiratory review (30.06.2018)“… Tuberculosis (TB) still represents a major public health issue in spite of the significant impact of the efforts made by the World Health Organization (WHO) …”
Volltext
Journal Article -
18
Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis
ISSN: 1201-9712, 1878-3511, 1878-3511Veröffentlicht: Canada Elsevier Ltd 01.11.2022Veröffentlicht in International journal of infectious diseases (01.11.2022)“… •MDR-TB is difficult to manage; updated clinical guidance of new drug use is needed•No recent systematic review/meta-analysis on delamanid (DLM) is …”
Volltext
Journal Article -
19
ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update
ISSN: 1399-3003, 1399-3003Veröffentlicht: England 01.05.2018Veröffentlicht in The European respiratory journal (01.05.2018)“… The International Standards for Tuberculosis Care define the essential level of care for managing patients who have or are presumed to have tuberculosis, or …”
Weitere Angaben
Journal Article -
20
Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
ISSN: 1080-6040, 1080-6059, 1080-6059Veröffentlicht: United States U.S. National Center for Infectious Diseases 01.10.2017Veröffentlicht in Emerging infectious diseases (01.10.2017)“… We report the experiences of 5 patients taking bedaquiline with delamanid in combination: 1 patient was cured; 3 culture converted, with 2 continuing and 1 …”
Volltext
Journal Article